Evidence map›Paper›PMID 33156820›Full record

ArticlePloS one2020

Colonisation with extended spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales in children admitted to a paediatric referral hospital in South Africa.

Babatunde O Ogunbosi, Clinton Moodley, Preneshni Naicker, James Nuttall, Colleen Bamford, Brian Eley

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Virulence · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Faecal Carriage of Multidrug ResistantThe East African health research journal · 2024
    Article
  14. Article
  15. Article
  16. Fecal Carriage of Carbapenem ResistantInfection and drug resistance · 2023
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Babatunde O OgunbosiPaediatric Infectious Diseases Unit, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.ORCID 0000-0002-7576-7367
Clinton MoodleyNational Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.ORCID 0000-0001-7547-9026
Preneshni NaickerNational Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
James NuttallPaediatric Infectious Diseases Unit, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
Colleen BamfordNational Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.ORCID 0000-0001-6236-879X
Brian EleyPaediatric Infectious Diseases Unit, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.ORCID 0000-0003-0811-0098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere are few studies describing colonisation with extended spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) and carbapenem-resistant Enterobacterales (CRE) among children in sub-Saharan Africa. Colonisation often precedes infection and multi-drug-resistant Enterobacterales are important causes of invasive infection.

methodsIn this prospective cross-sectional study, conducted between April and June 2017, 200 children in a tertiary academic hospital were screened by rectal swab for EBSL-PE and CRE. The resistance-conferring genes were identified using polymerase chain reaction technology. Risk factors for colonisation were also evaluated.

resultsOverall, 48% (96/200) of the children were colonised with at least one ESBL-PE, 8.3% (8/96) of these with 2 ESBL-PE, and one other child was colonised with a CRE (0.5% (1/200)). Common colonising ESBL-PE were Klebsiella pneumoniae (62.5%, 65/104) and Escherichia coli (34.6%, 36/104). The most frequent ESBL-conferring gene was blaCTX-M in 95% (76/80) of the isolates. No resistance- conferring gene was identified in the CRE isolate (Enterobacter cloacae). Most of the Klebsiella pneumoniae isolates were susceptible to piperacillin/tazobactam (86.2%) and amikacin (63.9%). Similarly, 94.4% and 97.2% of the Escherichia coli isolates were susceptible to piperacillin/tazobactam and amikacin, respectively. Hospitalisation for more than 7 days before study enrolment was associated with ESBL-PE colonisation.

conclusionApproximately half of the hospitalised children in this study were colonised with ESBL-PE. This highlights the need for improved infection prevention and control practices to limit the dissemination of these microorganisms.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesChildChild, PreschoolCross InfectionCross-Sectional StudiesDrug Resistance, Multiple, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsFemaleHospitalizationHospitals, PediatricHumansInfantInfant, NewbornAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemase

Identifiers

PMID33156820
PMCPMC7647087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.